Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Medtronic, Inc. (MDT) PT Raised to $93 at Oppenheimer Following 4Q
May 26, 2017 9:52 AM EDTOppenheimer raised its price target on Medtronic, Inc. (NYSE: MDT) to $93.00 (from $87.00) while maintaining a Outperform rating. MDT beat 4Q EPS by $0.02, led by higher constant-currency sales and gross margin along with lower FX headwind to EPS, somewhat offset by higher interest... More
Medtronic, Inc. (MDT) PT Raised to $94 at Barclays; Reiterates Overweight
May 26, 2017 7:59 AM EDTBarclays raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $92.00) while maintaining a Overweight... More
